Erratum: Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans (Science Translational Medicine (2016) (325ER3))

G. Reyes-Soffer, B. Moon, A. Hernandez-Ono, M. Dionizovick-Dimanovski, J. Jimenez, J. Obunike, T. Thomas, C. Ngai, N. Fontanez, D. S. Donovan, W. Karmally, S. Holleran, R. Ramakrishnan, R. S. Mittleman, H. N. Ginsberg

Résultat de rechercheexamen par les pairs

Langue d'origineEnglish
JournalScience Translational Medicine
Volume8
Numéro de publication325
DOI
Statut de publicationPublished - févr. 10 2016

ASJC Scopus Subject Areas

  • General Medicine

Citer

Reyes-Soffer, G., Moon, B., Hernandez-Ono, A., Dionizovick-Dimanovski, M., Jimenez, J., Obunike, J., Thomas, T., Ngai, C., Fontanez, N., Donovan, D. S., Karmally, W., Holleran, S., Ramakrishnan, R., Mittleman, R. S., & Ginsberg, H. N. (2016). Erratum: Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans (Science Translational Medicine (2016) (325ER3)). Science Translational Medicine, 8(325). https://doi.org/10.1126/scitranslmed.aaf3870